These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3035515)

  • 21. Modulation of receptors for thyrotropin-releasing hormone by benzodiazepines: brain regional differences.
    Sharif NA; Burt DR
    J Neurochem; 1984 Sep; 43(3):742-6. PubMed ID: 6146660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic thyrotropin-releasing hormone decreases the affinity and increases the number of its own receptor in the spinal cord.
    Prasad C; Spahn SA
    Neurosci Lett; 1989 Sep; 103(3):309-13. PubMed ID: 2554214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRH analog administration increases endogenous TRH levels in the central nervous system.
    Prasad C; Eloby-Childress S; Iriuchijima T; Wilber JF; Szirtes T; Kisfaludy L
    Neuroendocrinology; 1989 Feb; 49(2):219-22. PubMed ID: 2542830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
    J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of usefulness of DN-1417 for characterization of a CNS receptor for thyrotropin-releasing hormone.
    Hawkins EF; Wade R; Engel WK
    J Neurochem; 1987 Jul; 49(1):239-45. PubMed ID: 3035097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D; Seeman P
    J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of dopamine receptors in the release of thyrotropin-releasing hormone from the rat striatum and nucleus accumbens: an in vitro study.
    Przegaliński E; Jaworska L; Budziszewska B
    Neuropeptides; 1993 Nov; 25(5):277-82. PubMed ID: 7906871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide-dopamine interactions. IV. Effect of thyrotropin-releasing hormone on striatal dopaminergic neurons.
    Ikegami H; Spahn SA; Prasad C
    Peptides; 1989; 10(3):681-5. PubMed ID: 2528727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical and surgical lesions of rat olfactory bulb: changes in thyrotropin-releasing hormone and other systems.
    Sharif NA
    J Neurochem; 1988 Feb; 50(2):388-94. PubMed ID: 2826693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C; Ogren SO; Haglund L; Angeby T
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change in brain thyrotropin-releasing hormone (TRH) mechanism of amygdaloid kindled rats.
    Kajita S; Nakashima M; Okamoto M; Sato M; Ogawa N
    Jpn J Psychiatry Neurol; 1986 Sep; 40(3):345-7. PubMed ID: 3033370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN; Gulati A
    Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective cardiorespiratory activity of an iodinated analog of thyrotropin-releasing hormone (TRH).
    Paakkari I; Järvinen A; Vonhof S; Männistö PT; Cohen LA; Labroo VM; Feuerstein G
    Peptides; 1990; 11(5):939-44. PubMed ID: 2178251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in brain thyrotropin-releasing hormone (TRH) of El mice.
    Yamashita K; Nakashima M; Kajita S; Hiramatsu M; Ogawa N; Mori A; Sato M
    Jpn J Psychiatry Neurol; 1987 Sep; 41(3):383-5. PubMed ID: 2834594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and distribution of 3H-(3MeHis2)thyrotropin releasing hormone receptors in rat brain.
    Simasko SM; Horita A
    Life Sci; 1982 May; 30(21):1793-9. PubMed ID: 6285110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
    Yajima Y; Akita Y; Saito T
    Mol Pharmacol; 1988 Jun; 33(6):592-7. PubMed ID: 2837635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS.
    Ogawa N; Mizuno S; Nukina I; Tsukamoto S; Mori A
    Brain Res; 1983 Mar; 263(2):348-50. PubMed ID: 6301651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of chlordiazepoxide affects [3H][3-MeHis2]thyrotropin-releasing hormone binding in rat brain.
    Shimoda K; Mason GA; Walker CH; Garbutt JC; Prange AJ
    Peptides; 1991; 12(1):199-202. PubMed ID: 1647000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.